These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 18772035)

  • 21. [New implications for mental disorders treatment: pharmacogenetic studies of dopaminergic and serotonergic neurotransmission systems].
    Samochowiec J; Pełka-Wysiecka J; Rottmann M; Horodnicki J
    Psychiatr Pol; 2000; 34(4):561-76. PubMed ID: 11059257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The mesencephalic dopaminergic system. Implications for neuroleptic treatment].
    Beaufils B
    Encephale; 1990; 16(3):167-74. PubMed ID: 1974842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD).
    Oades RD
    Prog Brain Res; 2008; 172():543-65. PubMed ID: 18772050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin and molecular neuroimaging in humans using PET.
    Saulin A; Savli M; Lanzenberger R
    Amino Acids; 2012 Jun; 42(6):2039-57. PubMed ID: 21947614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonergic and dopaminergic modulation of attentional processes.
    Boulougouris V; Tsaltas E
    Prog Brain Res; 2008; 172():517-42. PubMed ID: 18772049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A new concept of antidepressant drugs action: clinical and preclinical data].
    Płaźnik A; Kostowski W
    Psychiatr Pol; 1994; 28(1):39-50. PubMed ID: 7910691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipsychotics in the early stage of development.
    Biedermann F; Fleischhacker WW
    Curr Opin Psychiatry; 2009 May; 22(3):326-30. PubMed ID: 19346948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Quetiapin in bipolar disorders].
    Sümegi A
    Neuropsychopharmacol Hung; 2008 Dec; 10(5):281-91. PubMed ID: 19419014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin in antipsychotic drugs action.
    Amato D
    Behav Brain Res; 2015 Jan; 277():125-35. PubMed ID: 25078293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin-dopamine interaction: an overview.
    Esposito E; Di Matteo V; Di Giovanni G
    Prog Brain Res; 2008; 172():3-6. PubMed ID: 18772025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonin and brain development.
    Sodhi MS; Sanders-Bush E
    Int Rev Neurobiol; 2004; 59():111-74. PubMed ID: 15006487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional polymorphisms in dopamine and serotonin pathway genes.
    D'Souza UM; Craig IW
    Hum Mutat; 2006 Jan; 27(1):1-13. PubMed ID: 16320307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New pharmacological approaches to the treatment of schizophrenia].
    Uzbay IT
    Turk Psikiyatri Derg; 2009; 20(2):175-82. PubMed ID: 19504368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants.
    Gaillard A; Decressac M; Frappé I; Fernagut PO; Prestoz L; Besnard S; Jaber M
    Neurobiol Dis; 2009 Sep; 35(3):477-88. PubMed ID: 19616502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The loudness dependence of the auditory evoked potential (LDAEP) as an in vivo biomarker of central serotonergic function in humans: rationale, evaluation and review of findings.
    O'Neill BV; Croft RJ; Nathan PJ
    Hum Psychopharmacol; 2008 Jul; 23(5):355-70. PubMed ID: 18421800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopaminergic mechanisms in the pathogenesis of schizophrenia.
    Goldstein M; Deutch AY
    FASEB J; 1992 Apr; 6(7):2413-21. PubMed ID: 1348713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study shows newer schizophrenia treatments no more effective than old.
    Frantz S
    Nat Rev Drug Discov; 2005 Nov; 4(11):872-3. PubMed ID: 16299914
    [No Abstract]   [Full Text] [Related]  

  • 38. [Physiopathology of schizophrenia. Some biologic aspects].
    Tissot R
    Schweiz Arch Neurol Neurochir Psychiatr; 1984; 135(1):29-40. PubMed ID: 6148787
    [No Abstract]   [Full Text] [Related]  

  • 39. Recent developments in the discovery of novel antipsychotic agents modualating dopamine and serotonin receptors.
    Li X; Ma S
    Curr Drug Targets; 2013 Jul; 14(8):899-918. PubMed ID: 23701299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role and therapeutic potential of 5-HT-moduline in psychiatry.
    Moret C; Grimaldi B; Massot O; Fillion G
    Semin Clin Neuropsychiatry; 2003 Apr; 8(2):137-46. PubMed ID: 12728412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.